Nxt-ID, a provider of healthcare devices and services, today announced that on January 4, 2021, it received written notice from Nasdaq confirming that the company has regained compliance with the applicable minimum bid price continued listing requirement and the matter is now closed.The company has cancelled its Special Meeting of Stockholders that was scheduled to be held on January 15, 2021. As a result of regaining compliance with the Minimum Bid Price Requirement, the Company no longer currently needs authorization to effect a reverse stock split of the Company's outstanding shares of Common Stock at this time.
Nxt-ID regains compliance with Nasdaq price requirement
